Literature DB >> 33069309

Characterising neuropsychiatric disorders in patients with COVID-19.

Dorothy Wade1, David Howell2, Matthew Beadman3, Alexandra Quigley4, Julie Highfield5.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33069309      PMCID： PMC7561314          DOI： 10.1016/S2215-0366(20)30380-1

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  4 in total

1.  The wide spectrum of COVID-19 neuropsychiatric complications within a multidisciplinary centre.

Authors:  Cécile Delorme; Marion Houot; Charlotte Rosso; Stéphanie Carvalho; Thomas Nedelec; Redwan Maatoug; Victor Pitron; Salimata Gassama; Sara Sambin; Stéphanie Bombois; Bastien Herlin; Gaëlle Ouvrard; Gaëlle Bruneteau; Adèle Hesters; Ana Zenovia Gales; Bruno Millet; Foudil Lamari; Stéphane Lehericy; Vincent Navarro; Benjamin Rohaut; Sophie Demeret; Thierry Maisonobe; Marion Yger; Bertrand Degos; Louise-Laure Mariani; Christophe Bouche; Nathalie Dzierzynski; Bruno Oquendo; Flora Ketz; An-Hung Nguyen; Aurélie Kas; Catherine Lubetzki; Jean-Yves Delattre; Jean-Christophe Corvol
Journal:  Brain Commun       Date:  2021-06-17

2.  A longer look at COVID-19 and neuropsychiatric outcomes.

Authors:  Jonathan P Rogers; Anthony S David
Journal:  Lancet Psychiatry       Date:  2021-04-06       Impact factor: 27.083

3.  Coronavirus infections from 2002 to 2021: neuropsychiatric manifestations.

Authors:  Amber Barthorpe; Jonathan P Rogers
Journal:  Sleep Med       Date:  2021-12-08       Impact factor: 4.842

4.  Neuropsychiatric sequelae of COVID-19: long-lasting, but not uniform.

Authors:  Jonathan P Rogers; Glyn Lewis
Journal:  Lancet Psychiatry       Date:  2022-08-17       Impact factor: 77.056
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.